| Literature DB >> 35516012 |
Qiaomei Jin1,2, Dongjian Zhang1,2, Jian Zhang1,2.
Abstract
A [3 + 2] annulation/C-arylation of isatin N,N'-cyclic azomethine imine 1,3-dipole 1 with in situ generated arynes has been established for the synthesis of 3,3-disubstituted oxindole scaffolds. These highly functionalized scaffolds were assembled in moderate yields (up to 85% yield). The novel spirooxindole scaffolds displayed moderate antitumor activities, which represented promising lead compounds for antitumor drug discovery. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35516012 PMCID: PMC9056323 DOI: 10.1039/d0ra06404a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Representative biologically active compounds containing the 3,3-disubstituted oxindole skeleton.
Scheme 1(a) Previous reports of isatin N,N′-cyclic azomethine imine 1,3-dipoles. (b) Design of the new [3 + 2] cycloaddition.
Optimization of the reaction conditionsa
|
| ||||||
|---|---|---|---|---|---|---|
| Entry | F-source (equiv.) | Additive (equiv.) | Solvent | Temp (°C) | Time (h) | Yield of 3a |
| 1 | CsF (2.0) | — | MeCN | rt | 2 | 20 |
| 2 | TBAF (2.0) | — | MeCN | rt | 2 | Trace |
| 3 | KF (2.0) | — | MeCN | rt | 2 | 15 |
| 4 | CsF (2.0) | 18-C-6 (2.0) | MeCN | rt | 2 | 55 |
| 5 | CsF (2.0) | 18-C-6 (2.0) | MeCN | 50 | 1 | 53 |
| 6 | CsF (2.5) | 18-C-6 (2.0) | MeCN | rt | 2 | 64 |
| 7 | CsF (3.0) | 18-C-6 (2.0) | MeCN | rt | 2 | 51 |
| 8 | CsF (4.0) | 18-C-6 (2.5) | MeCN | rt | 2 | 53 |
| 9 | CsF (2.5) | 18-C-6 (3.0) | MeCN | rt | 2 | 67 |
| 10 | CsF (2.5) | 18-C-6 (3.0) | DMF | rt | 2 | 45 |
| 11 | CsF (2.5) | 18-C-6 (3.0) | CH2Cl2 | rt | 2 | 33 |
|
|
|
|
|
|
|
|
| 13 | CsF (2.5) | 18-C-6 (3.5) | THF | rt | 2 | 69 |
| 14 | CsF (2.5) | 18-C-6 (3.0) | 1,4-Dioxane | rt | 2 | Trace |
| 15 | CsF (2.5) | 18-C-6 (3.0) | EA | rt | 4 | 55 |
| 16 | CsF (2.5) | 18-C-6 (3.0) | DCE | rt | 4 | 27 |
| 17 | CsF (2.5) | 18-C-6 (3.0) | MeOH | rt | 4 | 0 |
Unless noted otherwise, reaction of 1a (0.2 mmol), 2a (0.25 mmol), fluoride source (0.5 mmol) and 18-C-6 (0.6 mmol) was performed in 3.0 mL of solvent under Ar.
Isolated yield based on 1a.
Scheme 2The reaction scope.Typical conditions: reaction of 1 (0.2 mmol), 2 (0.25 mmol), CsF (0.5 mmol) and 18-C-6 (0.6 mmol) was performed in 3.0 mL of THF at room temperature under Ar. Isolated yield based on 1.
Scheme 3Follow-up Chemistry.
Scheme 4Plausible reaction mechanism.
In vitro antitumor activities of the target compounds (IC50, nM)
| Compounds | IC50 (nM) |
|---|---|
| Hep3B | |
| 3a | N.D. |
| 3b | N.D. |
| 3f | N.D. |
| 3g | N.D. |
| 3h | >10 000 |
| 3i | >10 000 |
| 3j | 4986.0 |
| 3k | >10 000 |
| 3l | N.D. |
| 3m/3m′ | N.D. |
| 3n/3n′ | N.D. |
| 3o/3o′ | N.D. |
| 3p/3p′ | N.D. |
| 4 | 601.7 |
| Infigratinib | 224.2 |
Not determined.